| Lokaci | Farashin Hasashen | Baya | Na tarihi | Hankali |
|---|---|---|---|---|
| Gobe | $85.97 ▲ +1.24% | Jiya | $84.48 ▼ -0.52% | Tomorrow's Rhythm Pharmaceuticals Inc. Common Stock (RYTM) setup is anchored to $84.92 and targets $85.97 (+1.24%). The near-term read is upside; watch $87.47 / $82.37 because daily realized volatility is about 6.38%. |
Tomorrow's Rhythm Pharmaceuticals Inc. Common Stock (RYTM) setup is anchored to $84.92 and targets $85.97 (+1.24%). The near-term read is upside; watch $87.47 / $82.37 because daily realized volatility is about 6.38%. | ||||
| Mako | $88.19 ▲ +3.85% | Makon da ya gabata | $83.55 ▼ -1.62% | The 7-day Rhythm Pharmaceuticals Inc. Common Stock model moves from $83.55 to $88.19 (+3.85%). It gives upside momentum context for this stock, so breaks around $87.47 / $82.37 matter more than a single tick. |
The 7-day Rhythm Pharmaceuticals Inc. Common Stock model moves from $83.55 to $88.19 (+3.85%). It gives upside momentum context for this stock, so breaks around $87.47 / $82.37 matter more than a single tick. | ||||
| Watan | $91.88 ▲ +8.20% | A watan da ya gabata | $82.00 ▼ -3.44% | The 1-month Rhythm Pharmaceuticals Inc. Common Stock target is $91.88 (+8.20%), compared with the live reference near $84.92. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Rhythm Pharmaceuticals Inc. Common Stock target is $91.88 (+8.20%), compared with the live reference near $84.92. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Shekara | $97.42 ▲ +14.72% | Shekaran da ya gabata | $79.67 ▼ -6.18% | The 1-year Rhythm Pharmaceuticals Inc. Common Stock scenario points to $97.42 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Rhythm Pharmaceuticals Inc. Common Stock scenario points to $97.42 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| Shekaru 5 | $110.40 ▲ +30.00% | Shekaru 5 da suka gabata | $74.22 ▼ -12.60% | The 5-year Rhythm Pharmaceuticals Inc. Common Stock view is $110.40 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Rhythm Pharmaceuticals Inc. Common Stock view is $110.40 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Mai nuna alama | Daraja | Sigina |
|---|---|---|
| Price | $84.92 | Mid |
| Daily Change | -3.19% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 64% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $84.92 | Daily Change | -3.19% |
| Market Cap | $5.80B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.